A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC

Clinical trial NCT06383052 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06383052
Sponsor: Norroy Bioscience Co., LTD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer

Start date: 2024-04-26
Primary completion: 2025-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.